2019
DOI: 10.1002/stem.3072
|View full text |Cite
|
Sign up to set email alerts
|

Herpes Simplex Virus Type-1 Infection Impairs Adult Hippocampal Neurogenesis via Amyloid-β Protein Accumulation

Abstract: We previously reported that Herpes simplex virus type-1 (HSV-1) infection of cultured neurons triggered intracellular accumulation of amyloid-β protein (Aβ) markedly impinging on neuronal functions. Here, we demonstrated that HSV-1 affects in vitro and in vivo adult hippocampal neurogenesis by reducing neural stem/progenitor cell (NSC) proliferation and their neuronal differentiation via intracellular Aβ accumulation. Specifically, cultured NSCs were more permissive for HSV-1 replication than mature neurons an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
54
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 60 publications
(58 citation statements)
references
References 76 publications
3
54
0
1
Order By: Relevance
“…In addition, the virus was reported to trigger several neurotoxic pathways in neurons, including those related to the hyperphosphorylation/aggregation of the microtubule-associated tau protein [ 21 ] and synaptic dysfunction [ 22 ], the transcription of neurotoxic genes [ 23 ], and DNA damage [ 24 ]. Recently, by using a mouse model of recurrent HSV-1 infection, we showed the long-term dangerous effects of repeated HSV-1 replications in the brain (e.g., Aβ accumulation and deposition in plaques, tau hyperphosphorylation and aggregation, neuroinflammation), providing a first demonstration of the cause–effect relationship between HSV-1 reactivations and accumulation of AD molecular hallmarks, including cognitive deficits [ 25 ] and impaired adult neurogenesis [ 26 ]. Interestingly, HSV-1 life cycle is reported to induce an intracellular redox imbalance in host cells [ 27 , 28 ], and in vivo evidence demonstrated that this occurs also in the brain [ 29 ].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the virus was reported to trigger several neurotoxic pathways in neurons, including those related to the hyperphosphorylation/aggregation of the microtubule-associated tau protein [ 21 ] and synaptic dysfunction [ 22 ], the transcription of neurotoxic genes [ 23 ], and DNA damage [ 24 ]. Recently, by using a mouse model of recurrent HSV-1 infection, we showed the long-term dangerous effects of repeated HSV-1 replications in the brain (e.g., Aβ accumulation and deposition in plaques, tau hyperphosphorylation and aggregation, neuroinflammation), providing a first demonstration of the cause–effect relationship between HSV-1 reactivations and accumulation of AD molecular hallmarks, including cognitive deficits [ 25 ] and impaired adult neurogenesis [ 26 ]. Interestingly, HSV-1 life cycle is reported to induce an intracellular redox imbalance in host cells [ 27 , 28 ], and in vivo evidence demonstrated that this occurs also in the brain [ 29 ].…”
Section: Introductionmentioning
confidence: 99%
“…This observation provides further evidence for the higher susceptibility of NPCs than of neurons to HSV-1. These data are particularly relevant in light of recent data that associate HSV-1 with Alzheimer's disease (31) and a recent report that showed accumulation of beta amyloid in neural stem cells harboring HSV-1 lytic infection (32).…”
Section: Fig 4 Legend (Continued)mentioning
confidence: 85%
“…HSV-1 has also been found to infect the hippocampus region at a greater rate; the same area found to have greater amounts of Aβ plaques in AD [ 81 ]. In vitro studies observed cells co-cultured with either HSV-1, HSV-2, P. gingivalis or B. burgdoferi to have increased intracellular concentrations of Aβ [ 80 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 ]. Furthermore, HSV-1 has been associated with the inhibition of the non-amyloidogenic pathway of APP metabolism, and the increased expression of β-secretase.…”
Section: Antimicrobial Protection Hypothesismentioning
confidence: 99%